Diabetes Nutrition Algorithms - Sugars: Galactose- and Fiber-induced Metabolic Improvement in the Dietetic Treatment of Type 2 Diabetes
DiNA-S DiNA-F
1 other identifier
interventional
60
1 country
1
Brief Summary
In animal models and retrospective studies, certain food components such as sugars and fiber have been detected as potential agents to influence development and progress of type 2 diabetes. The DiNA study prospectively investigates, if non-soluble non-fermentable fibers (vs. soluble ones) and galactose (vs. palatinose) are capable to improvement metabolic parameters in patients with long-term type 2 diabetes and intensive insulin treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable type-2-diabetes
Started Nov 2012
Longer than P75 for not_applicable type-2-diabetes
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2012
CompletedFirst Submitted
Initial submission to the registry
January 23, 2013
CompletedFirst Posted
Study publicly available on registry
January 25, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2021
CompletedJune 24, 2020
June 1, 2020
8.9 years
January 23, 2013
June 23, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
metabolic improvement of type 2 diabetes
metabolic improvement of type 2 diabetes, as to be shown via hyperinsulinemic-euglycaemic clamp, mixed-meal test and daily demand of insulin units
4 weeks
Study Arms (4)
pure galactose
ACTIVE COMPARATOR5 grams of galactose, three times a day with the main meals, duration: 4 weeks
pure palatinose
PLACEBO COMPARATOR5 grams of palatinose, three times a day with the main meals, duration: 4 weeks
soluble non-fermentable fibers
PLACEBO COMPARATOR5 grams of soluble non-fermentable fibers, three times a day with the main meals, duration: 4 weeks
non-soluble non-fermentable fibers
ACTIVE COMPARATOR5 grams of non-soluble non-fermentable fibers, three times a day with each main meal, duration: 4 weeks
Interventions
Eligibility Criteria
You may qualify if:
- type 2 diabetes, insulin-dependent
- high insulin resistance
You may not qualify if:
- accompanying disease, medication or metabolic disorder, which interact with glucose metabolism or eating behavior (e.g. renal insufficiency, major cardial insuffiency, untreated hypothyreosis, corticoid treatment, depression and other psychiatric disorders...)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- German Institute of Human Nutritionlead
- Firma Rettenmeier & Söhne (Company)collaborator
- German Center for Diabetes Researchcollaborator
Study Sites (1)
Charité-Klinikum Benjamin Franklin
Berlin, 12203, Germany
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andreas F.H. Pfeiffer, Prof. Dr. med.
German Institute for Human Nutrition
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of the Department for Clinical Nutrition
Study Record Dates
First Submitted
January 23, 2013
First Posted
January 25, 2013
Study Start
November 1, 2012
Primary Completion
October 1, 2021
Study Completion
December 1, 2021
Last Updated
June 24, 2020
Record last verified: 2020-06